Hong-Gyun Lee,Joseph M. Rone,Zhaorong Li,Camilo Faust Akl,Seung Won Shin,Joon-Hyuk Lee,Lucas E. Flausino,Florian Pernin,Chun-Cheih Chao,Kilian L. Kleemann,Lena Srun,Tomer Illouz,Federico Giovannoni,Marc Charabati,Liliana M. Sanmarco,Jessica E. Kenison,Gavin Piester,Stephanie E. J. Zandee,Jack Antel,Veit Rothhammer,Michael A. Wheeler,Alexandre Prat,Iain C. Clark,Francisco J. Quintana

Abstract:Astrocytes play important roles in the central nervous system (CNS) physiology and pathology. Indeed, astrocyte subsets defined by specific transcriptional activation states contribute to the pathology of neurologic diseases, including multiple sclerosis (MS) and its pre-clinical model experimental autoimmune encephalomyelitis (EAE) . However, little is known about the stability of these disease-associated astrocyte subsets, their regulation, and whether they integrate past stimulation events to respond to subsequent challenges. Here, we describe the identification of an epigenetically controlled memory astrocyte subset which exhibits exacerbated pro-inflammatory responses upon re-challenge. Specifically, using a combination of single-cell RNA sequencing (scRNA-seq), assay for transposase-accessible chromatin with sequencing (ATAC–seq), chromatin immunoprecipitation with sequencing (ChIP–seq), focused interrogation of cells by nucleic acid detection and sequencing (FIND-seq), and cell-specific CRISPR/Cas9-based genetic perturbation studies we established that astrocyte memory is controlled by the metabolic enzyme ATP citrate lyase (ACLY), which produces acetyl coenzyme A (acetyl-CoA) used by the histone acetyltransferase p300 to control chromatin accessibility. ACLY p300 memory astrocytes are increased in acute and chronic EAE models; the genetic targeting of ACLY p300 astrocytes using CRISPR/Cas9 ameliorated EAE. We also detected responses consistent with a pro-inflammatory memory phenotype in human astrocytes ; scRNA-seq and immunohistochemistry studies detected increased ACLY p300 astrocytes in chronic MS lesions. In summary, these studies define an epigenetically controlled memory astrocyte subset that promotes CNS pathology in EAE and, potentially, MS. These findings may guide novel therapeutic approaches for MS and other neurologic diseases.

Astrocyte cells in the brain have immune memory

Astrocytes remember inflammation

Astrocytes ACLYmate to chronic neuroinflammation

Emerging roles of astrocytes as immune effectors in the central nervous system

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Astrocyte-Mediated Neuroinflammation in Neurological Conditions

Disease-associated astrocyte epigenetic memory promotes CNS pathology

Live Imaging of Astrocyte Responses to Acute Injury Reveals Selective Juxtavascular Proliferation

Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination

Immune Functions of Astrocytes in Viral Neuroinfections

Astrocytic crosstalk with brain and immune cells in healthy and diseased conditions

Innate immune memory in the brain shapes neurological disease hallmarks

Regionally diverse astrocyte subtypes and their heterogeneous response to EAE

The anti-inflammatory astrocyte revealed: the role of the microbiome in shaping brain defences

Reactive astrocytes generated from human iPSC are pro-inflammatory and display altered metabolism

Astrocytes in human central nervous system diseases: a frontier for new therapies

Essential Role of Astrocytes in Learning and Memory

Astrocytic determinant of the fate of long‐term memory

Repetitive injury and absence of monocytes promote astrocyte self‐renewal and neurological recovery

Learning-associated astrocyte ensembles regulate memory recall